Regenxbio (RGNX) Current Taxes (2018 - 2022)
Regenxbio (RGNX) posted quarterly Current Taxes of $12.7 million for Q1 2022, up 216.4% year-over-year from $4.0 million in Q1 2021, and up 11.89% quarter-over-quarter from $11.3 million in Q4 2021.
Regenxbio (RGNX) Current Taxes (2018 - 2022) Analysis & Trends
Regenxbio's Current Taxes history runs 5 years deep, the most recent figure standing at $12.7 million for Q1 2022.
- In Q1 2022, Current Taxes rose 216.4% year-over-year to $12.7 million; the TTM figure through Mar 2022 stood at $12.7 million (up 216.4% YoY), while the FY2021 annual figure was $11.3 million, up 261.24% from the prior year.
- Current Taxes for Q1 2022 stood at $12.7 million, up from $11.3 million in the prior quarter.
- The five-year high for Current Taxes was $12.7 million in Q1 2022, with the low at $508000.0 in Q3 2019.
- The 5-year median for Current Taxes is $1.8 million (2018), against an average of $3.8 million.
- The sharpest annual moves came in 2019 and 2021: Current Taxes plunged 76.88% in 2019, then surged 261.24% in 2021.
- Regenxbio's Current Taxes stood at $726000.0 in 2018, then slumped by 30.03% to $508000.0 in 2019, then soared by 517.13% to $3.1 million in 2020, then soared by 261.24% to $11.3 million in 2021, then climbed by 11.89% to $12.7 million in 2022.
- Business Quant data shows RGNX's Current Taxes at $12.7 million in Q1 2022, $11.3 million in Q4 2021, and $4.0 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 49.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 76.32 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 59,089.99 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 12.67 Mn |
| Dec 31, 2021 | 11.33 Mn |
| Mar 31, 2021 | 4.01 Mn |
| Dec 31, 2020 | 3.14 Mn |
| Sep 30, 2019 | 508,000.00 |
| Jun 30, 2019 | 564,000.00 |
| Mar 31, 2019 | 1.13 Mn |
| Dec 31, 2018 | 726,000.00 |
| Sep 30, 2018 | 1.14 Mn |
| Jun 30, 2018 | 2.44 Mn |